February 27, 2018 / 9:04 PM / 8 months ago

BRIEF-Avexis Q4 Loss Per Share $2.55

Feb 27 (Reuters) - Avexis Inc:

* AVEXIS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL AND OPERATING RESULTS

* Q4 LOSS PER SHARE $2.55

* ‍ON TRACK TO REQUEST PRE-BLA MEETING WITH FDA IN Q2 2018​

* ‍INTENDS TO INITIATE PIVOTAL TRIAL IN SMA TYPE 1 IN EUROPE AND MULTI-NATIONAL PRE-SYMPTOMATIC SMA STUDY IN FIRST HALF OF 2018​

* ‍ANTICIPATES IND SUBMISSIONS FOR RETT SYNDROME AND GENETIC ALS IN LATE 2018/EARLY 2019​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below